NFKB1 and cancer: For instance, MAP3K8, MAP3K13, NCF2, NF-κB (family), NFATC2, NF-κB (complex), and NR2F2 were significantly disturbed by myricetin treatment, which are belonging to cancer related MAPK/NF-κB inflammatory signaling pathway.